The current stock price of ASBP is 1.35 USD. In the past month the price decreased by -57.71%.
Over the last trailing twelve months ASBP reported a non-GAAP Earnings per Share(EPS) of -1.65. The EPS decreased by -282.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1194.47% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.25 | 959.759B | ||
| JNJ | JOHNSON & JOHNSON | 20.67 | 580.304B | ||
| MRK | MERCK & CO. INC. | 22.05 | 296.13B | ||
| PFE | PFIZER INC | 9.23 | 157.665B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.85 | 122.002B | ||
| ZTS | ZOETIS INC | 18.74 | 56.704B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.53 | 25.543B | ||
| VTRS | VIATRIS INC | 6.38 | 18.578B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.59 | 12.774B | ||
| AXSM | AXSOME THERAPEUTICS INC | 227.37 | 9.387B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
ASPIRE BIOPHARMA HOLDINGS IN
194 Candelaro Drive, #233
Humacao NEW YORK PR
Employees: 0
Phone: 15617048527
Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
The current stock price of ASBP is 1.35 USD. The price decreased by -4.26% in the last trading session.
ASBP does not pay a dividend.
ASBP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) currently has 0 employees.
You can find the ownership structure of ASPIRE BIOPHARMA HOLDINGS IN (ASBP) on the Ownership tab.